MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1474-760X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype ; volume:8 ; number:10 ; day:08 ; month:10 ; year:2007 ; pages:1-16 ; date:10.2007
Genome biology ; 8, Heft 10 (08.10.2007), 1-16, 10.2007
- Urheber
-
Blenkiron, Cherie
- Beteiligte Personen und Organisationen
-
Goldstein, Leonard D.
Thorne, Natalie P.
Spiteri, Inmaculada
Chin, Suet-Feung
Dunning, Mark J.
Barbosa-Morais, Nuno L.
Teschendorff, Andrew E.
Green, Andrew R.
Ellis, Ian O.
Tavaré, Simon
Caldas, Carlos
Miska, Eric
SpringerLink (Online service)
- DOI
-
10.1186/gb-2007-8-10-r214
- URN
-
urn:nbn:de:1111-2016050140940
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.04.2025, 11:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Blenkiron, Cherie
- Goldstein, Leonard D.
- Thorne, Natalie P.
- Spiteri, Inmaculada
- Chin, Suet-Feung
- Dunning, Mark J.
- Barbosa-Morais, Nuno L.
- Teschendorff, Andrew E.
- Green, Andrew R.
- Ellis, Ian O.
- Tavaré, Simon
- Caldas, Carlos
- Miska, Eric
- SpringerLink (Online service)
Ähnliche Objekte (12)
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease
MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction
Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Nuclear receptor profiling for subtype classification and as prognostic markers in 33 cancer types
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease
Dual-center, dual-platform microRNA profiling identifies potential plasma biomarkers of adult temporal lobe epilepsy
Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease
MicroRNA profiling of ovarian granulosa cell tumours reveals novel diagnostic and prognostic markers
Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung
DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease